Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor–microenvironment interactions

A comprehensive overview of breast cancer development and progression suggests that the process is influenced by intrinsic properties of the tumor cells, as well as by microenvironmental factors. Indeed, in breast carcinoma, an intensive interplay exists between the tumor cells on one hand, and inflammatory cells/cytokines/chemokines on the other. The purpose of the present review is to outline the reciprocal interactions that exist between these different elements, and to shed light on their potential involvement in breast cancer development and progression.

[1]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[2]  K. Matsushima,et al.  Molecular Analysis of the Inhibition of Monocyte Chemoattractant Protein-1 Gene Expression by Estrogens and Xenoestrogens in MCF-7 Cells1. , 2000, Endocrinology.

[3]  F. Balkwill.  Tumor necrosis factor or tumor promoting factor? , 2002, Cytokine & growth factor reviews.

[4]  S. Kurtzman,et al.  Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue. , 1998, Anticancer research.

[5]  C. Lewis,et al.  Tumour‐associated leucocytes: Friends or foes in breast carcinoma , 1994, The Journal of pathology.

[6]  S. Sheen-Chen,et al.  Serum concentration of tumor necrosis factor in patients with breast cancer , 1997, Breast Cancer Research and Treatment.

[7]  S. Ljunghall,et al.  Regulation of Interleukin‐6 Secretion from Mononuclear Blood Cells by Extracellular Calcium , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[8]  R. Rees,et al.  Chemokines induce migrational responses in human breast carcinoma cell lines , 1997, International journal of cancer.

[9]  Manuel A. González,et al.  A role for chemokine receptor transactivation in growth factor signaling , 2001, EMBO reports.

[10]  J. Kurebayashi.  Regulation of interleukin-6 secretion from breast cancer cells and its clinical implications , 2000, Breast cancer.

[11]  A. Mantovani,et al.  The origin and function of tumor-associated macrophages. , 1992, Immunology today.

[12]  A. Mackiewicz,et al.  Expression of interleukin‐6, interleukin‐6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma , 2000, Cancer.

[13]  J. Hadden.  The immunology and immunotherapy of breast cancer: an update. , 1999, International journal of immunopharmacology.

[14]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[15]  G. Heppner,et al.  Immunological enhancement of breast cancer , 1997, Parasitology.

[16]  A. Green,et al.  Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin‐8 as a potential regulatory factor in breast tumours , 1997, International journal of cancer.

[17]  J. Ward,et al.  Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression. , 2000, Blood.

[18]  L. Hayman,et al.  Correspondence , 1992, Neuroradiology.

[19]  K. Cornetta,et al.  The CC Chemokine CKβ-11/MIP-3β/ELC/Exodus 3 Mediates Tumor Rejection of Murine Breast Cancer Cells Through NK Cells1 , 2000, The Journal of Immunology.

[20]  H. Saji,et al.  Significant correlation of monocyte chemoattractant protein‐1 expression with neovascularization and progression of breast carcinoma , 2001, Cancer.

[21]  J. Manivel,et al.  A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. , 2001, The American journal of pathology.

[22]  A. Ben-Baruch,et al.  Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma. , 1999, Cancer research.

[23]  M. Weil,et al.  The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. , 2002, Cancer research.

[24]  D. Miles,et al.  Expression of tumour necrosis factor (TNFα) and its receptors in benign and malignant breast tissue , 1994 .

[25]  H. Augustin,et al.  Induction of inflammatory angiogenesis by monocyte chemoattractant protein‐1 , 1999, International journal of cancer.

[26]  K. Matsushima,et al.  Molecular analysis of the inhibition of monocyte chemoattractant protein-1 gene expression by estrogens and xenoestrogens in MCF-7 cells. , 2000, Endocrinology.

[27]  Noam Brown,et al.  Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors , 2001, Journal of leukocyte biology.

[28]  C. Mackay,et al.  The role of chemokine receptors in primary, effector, and memory immune responses. , 2000, Annual review of immunology.

[29]  H. Saji,et al.  Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  J. Kaur,et al.  Intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and regulated on activation normal T cell expressed and secreted are expressed by human breast carcinoma cells and support eosinophil adhesion and activation. , 2000, The American journal of pathology.

[31]  A. Harris,et al.  Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.

[32]  C. Tannenbaum,et al.  Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma. , 2002, Cancer research.

[33]  C. Cohen,et al.  Chemokine-Induced Secretion of Gelatinase B in Primary Human Monocytes , 2001, Biological chemistry.

[34]  Y. Ozaki,et al.  Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  Liang Jin,et al.  Expression of interleukin‐1β in human breast carcinoma , 1997 .

[36]  S. Fox,et al.  Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. , 1998, British Journal of Cancer.